CPHA Canvax
CPHA Canvax

Frequently asked questions: Myocarditis and Pericarditis After COVID-19 Vaccines

LINK
Bookmark

Background Knowledge

Link
Published: 2021 Region: National Audience: General Public, Health Care Professional Product Type: Fact Sheet Language: English Population: Adolescents, Adults Organization: University of Waterloo School of Pharmacy

Category

Vaccine Safety and Development,Vaccine Safety,Adverse Events Following Immunization (AEFI),Program Planning and Delivery,Promotion and Communication,Communication,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and Development
Vaccine Safety
Adverse Events Following Immunization (AEFI)
Program Planning and Delivery
Promotion and Communication
Communication
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.

Login or register to comment